HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

7,8- dimethyl- 10- (3- chlorobenzyl)isoalloxazine

mineralocorticord antag

Also Known As:

7,8-DCBI

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Pteridines: 147
      - Flavins: 50
        7,8-dimethyl-10-(3-chlorobenzyl)isoalloxazine: 1
  - 3-Ring Heterocyclic Compounds
    - Flavins: 50
      - 7,8-dimethyl-10-(3-chlorobenzyl)isoalloxazine: 1
Enzymes and Coenzymes: 1
- Coenzymes: 558
  - Flavins: 50
    - 7,8-dimethyl-10-(3-chlorobenzyl)isoalloxazine: 1
Biological Factors: 2472
- Biological Pigments: 1
  - Flavins: 50
    - 7,8-dimethyl-10-(3-chlorobenzyl)isoalloxazine: 1

Related Diseases

1.	Hypertension (High Blood Pressure) 08/01/1985 - "Our study was designed to use the antimineralocorticoid property of the riboflavin analogue 7,8-dimethyl-10-(3-chlorobenzyl)isoalloxazine (CBI) to investigate the involvement of mineralocorticoids in the hypertension of the Kyoto strain of the spontaneously hypertensive rat (SHR) and Dahl salt-sensitive (S) rat. "

Related Drugs and Biologics

1.	Salts
2.	Riboflavin (Vitamin B2)
3.	Mineralocorticoids